Theriva Biologics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
AMEX
The Jeffrey Matthew Gryga Irrevocable Trust and Jeffrey Matthew Gryga have disclosed a beneficial ownership of 7.7% in Theriva Biologics, Inc. common stock.
AMEX
Empery Asset Management, LP and its managing members reported a 4.99% passive beneficial ownership stake in Theriva Biologics, Inc. through warrants.
AMEX
Empery Asset Management, LP, along with its managing members Ryan M. Lane and Martin D. Hoe, has disclosed a 9.99% beneficial ownership stake in Theriva Biologics, Inc., including shares issuable from warrants.
AMEX
CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a passive 4.9% beneficial ownership stake in Theriva Biologics, Inc. as of December 31, 2024.